Antiangiogenic Therapeutic mRNA Delivery Using Lung-Selective Polymeric Nanomedicine for Lung Cancer Treatment-Reference-Cited by-同舟云学术

Antiangiogenic Therapeutic mRNA Delivery Using Lung-Selective Polymeric Nanomedicine for Lung Cancer Treatment

Published:2024-03-07 Issue:11 Volume:18 Page:8392-8410
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Le Ngoc Duy¹,Nguyen Bao Loc¹,Patil Basavaraj Rudragouda¹,Chun HeeSang¹,Kim SiYoon¹,Nguyen Thi Oanh Oanh¹,Mishra Sunil¹^ORCID,Tandukar Sudarshan¹,Chang Jae-Hoon¹,Kim Dong Young¹,Jin Sung Giu²^ORCID,Choi Han-Gon³,Ku Sae Kwang⁴,Kim Jeonghwan¹^ORCID,Kim Jong Oh¹^ORCID

Affiliation:

1. College of Pharmacy, Yeungnam University, Gyeongsan, 38541, Republic of Korea

2. Department of Pharmaceutical Engineering, Dankook University, Cheonan, 31116, Republic of Korea

3. College of Pharmacy, Hanyang University, Ansan, 15588, Republic of Korea

4. College of Korean Medicine, Daegu Haany University, Gyeongsan, 38610, Republic of Korea

Funder

National Research Foundation of Korea

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.3c13039

Reference67 articles.

1. The role of microenvironment in tumor angiogenesis

2. Tumor angiogenesis: molecular pathways and therapeutic targets

3. VEGF in Signaling and Disease: Beyond Discovery and Development

4. Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook

5. Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ligand-free biodegradable poly(beta-amino ester) nanoparticles for targeted systemic delivery of mRNA to the lungs;Biomaterials;2025-02

2. Latest Delivery Advancements of Lipid Nanoparticles for Cancer Treatment;ASSAY and Drug Development Technologies;2024-09-01

3. Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma;Cancers;2024-08-27

4. Optimal development of apoptotic cells-mimicking liposomes targeting macrophages;Journal of Nanobiotechnology;2024-08-21

5. Targeted delivery of type I TGF-β receptor-mimicking peptide to fibrotic kidney for improving kidney fibrosis therapy via enhancing the inhibition of TGF-β1/Smad and p38 MAPK pathways;International Immunopharmacology;2024-08